The latest report from Meticulous Research® estimates that the global pharmacovigilance market is set to grow significantly, reaching $18.05 billion by 2031, at a CAGR of 10.7% from 2024 to 2031. The market's growth is fueled by increasing concerns over drug toxicity, stringent regulatory requirements, rising investments in pharmaceutical R&D, and the growing demand for new drug...

The Pharmacovigilance Market size was valued at $6.6 Bn in 2022 and is expected to reach $11.17 by 2030 and grow at a CAGR of 6.8% over the forecast period of 2023-2030. In the ever-evolving world of pharmaceuticals, ensuring drug safety is paramount. The global pharmacovigilance market, dedicated to monitoring and mitigating adverse drug reactions (ADRs), is experiencing robust growth,...

According to a new report published by UnivDatos Markets Insights, the Pharmacovigilance Software Market was valued at more than USD 4 billion in 2020 and is expected to grow at a CAGR of around 8% from 2022-2028. The analysis has been segmented into Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software); Mode of...

According to a new report published by UnivDatos Markets Insights, the Pharmacovigilance Software Market was valued at more than USD 4 billion in 2020 and is expected to grow at a CAGR of around 8% from 2022-2028. The analysis has been segmented into Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software); Mode of...

According to a new report published by UnivDatos Markets Insights, the Pharmacovigilance Software Market was valued at more than USD 4 billion in 2020 and is expected to grow at a CAGR of around 8% from 2022-2028. The analysis has been segmented into Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software); Mode of...